Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001478685 | SCV001682960 | likely benign | Gorlin syndrome; Medulloblastoma | 2022-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384776 | SCV002689807 | likely benign | Hereditary cancer-predisposing syndrome | 2020-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003426138 | SCV004127280 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | SUFU: BP4, BP7 |